Graphite Bio, Inc. has entered into a merger agreement with Lenz Therapeutics, Inc., with Lenz becoming a wholly owned subsidiary of Graphite; stockholders voted and approved the proposals related to the merger agreement.
AI Assistant
LENZ THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.